Thermo Fisher Scientific Inc
(BSP:TMOS34)
R$
70.76
0.78 (1.11%)
Market Cap: 1.30 Tn
Enterprise Value: 1.44 Tn
PE Ratio: 38.07
PB Ratio: 4.94
GF Score: 89/100 Thermo Fisher Scientific Inc at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript
Jan 06, 2022 / 02:00PM GMT
Release Date Price:
R$74.01
(+0.75%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Good morning, everyone, and good afternoon. I'm Matt Sykes, the senior life science tools and diagnostics analyst at Goldman Sachs. And we have the pleasure today of hosting Marc Casper, the Chairman, President and CEO of Thermo Fisher. Marc, Happy New Year, and thanks for joining.
Marc N. Casper
Thermo Fisher Scientific Inc. - Chairman, President & CEO
Matt, happy New Year, and thanks for having me. It's great to be with you today, albeit virtually.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Well, I thought I'd let set the stage for us for the first few minutes. You hosted your Investor Day in September where you upgraded your long-term growth guidance and then reported strong numbers in Q3. Perhaps you can share a bit on the -- a bit of the trends that you've been seeing within your end markets, and what has changed, if anything, over the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot